UK expands mandatory infectious disease reporting requirements
The update is aimed at strengthening local and national surveillance
Read More
Tag: infectious diseases
WHO report highlights resurgence of tuberculosis
Approximately 8.2 million people were diagnosed with the infectious disease in 2023
Read More
Study reveals mobile phone data can help map the spread of pathogens
Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide
Read More
Researchers identify group of biological markers found in high levels in TB patients
According to the World Health Organization, TB is responsible for over one million annual deaths
Read More
NHS campaign urges over 900,000 young adults to catch up on missed MMR vaccine
Between October 2023 and March 2024, the UKHSA said that 733 cases of measles were reported in England
Read More
PhaSER Biomedical receives $2.3m drug discovery grant from the Gates Foundation
Every year, tuberculosis, malaria and HIV cause over five million deaths worldwide
Read More
Evonetix installs first DNA synthesis development platform at ICL
It will be the company’s first platform to be installed in an external scientific setting
Read More
Evaxion validates its infectious disease AI vaccine platform
The platform identifies antigens to fight against bacterial infectious disease
Read More
GSK shares promising results from shingles vaccine trial
The varicella zoster virus that causes shingles and chicken pox is typically present in over 90% of adults globally
Read More
Research shows new technique could cut time to detect polio in half
This is the first time that this type of scientific method has been used to detect polio
Read More
Positive Phase III results for Valneva’s chikungunya vaccine
Neutralising antibody titers were observed in 98.5% of subjects
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
